Ondansetron Tablet, Orally Disintegrating
Product Images NDC 71335-3073

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 71335-3073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (Lbl713353073)

Label (Lbl713353073)
This text includes information about Ondansetron orally disintegrating tablets containing 8 mg of Ondansetron USP. The tablets are intended for individuals with phenylketonuria as they contain phenylalanine. The usual dosage information can be accessed by scanning the QR code on the package insert. Storage instructions suggest keeping the tablets at 20° to 25°C (68° to 77°F) in a light-resistant container at controlled room temperature. The tablets are to be dispensed in a child-resistant closure container and should only be removed from the bottle right before use. The product comes in a bottle with 30 tablets and is labeled for prescription use only. The tablets are repackaged by Bryant Ranch Prepack, Inc. and manufactured by Aurobindo Pharma.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.